Pediatrix Medical Group, Inc. (MD) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	2.0B	1.9B	2.0B	2.0B	2.0B
Cost of Revenue	1.4B	1.4B	1.6B	1.6B	1.5B
Gross Profit	506.1M	471.9M	454.3M	421.6M	467.0M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	248.0M	240.8M	238.4M	227.5M	231.4M
General & Admin Expense	248.0M	240.8M	238.4M	227.5M	231.4M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	31.9M	—	284.6M	186.7M	62.9M
Total Operating Expenses	279.9M	240.8M	523.1M	414.2M	294.3M
Cost and Expenses	1.7B	1.7B	2.1B	2.0B	1.8B
Operating Income (EBIT)	226.2M	231.1M	(68.7M)	7.3M	172.7M
Non-Operating
Interest Income	4.7M	19.0M	—	—	—
Interest Expense	28.2M	36.0M	40.7M	42.1M	39.7M
Net Interest Income	(23.5M)	(16.9M)	(40.7M)	(42.1M)	(39.7M)
Other Non-Op Income/Expense	(8.0K)	(14.7M)	(32.6M)	(55.7M)	(91.3M)
Non-Operating Income (excl Interest)	(17.7M)	(21.3M)	(8.1M)	13.6M	51.6M
EBT (Pre-Tax Income)	226.2M	216.4M	(101.3M)	(48.4M)	81.4M
Income Tax Expense	51.4M	51.0M	(2.3M)	12.0M	18.8M
Bottom Line
Net Income	174.8M	165.4M	(99.1M)	(60.4M)	66.3M
Earnings from Cont. Ops	174.8M	165.4M	(99.1M)	(60.4M)	62.6M
Earnings from Discont. Ops	—	—	—	—	3.8M
Bottom Line Net Income	174.8M	165.4M	(99.1M)	(60.4M)	66.3M
Per Share
Basic EPS	$2.11	$1.94	($1.19)	($0.73)	$0.80
Diluted EPS	$2.09	$1.94	($1.19)	($0.73)	$0.79
Revenue Per Share	$24.55	$22.45	$24.16	$24.27	$23.77
Shares
Basic Shares Outstanding	79.4M	85.3M	83.3M	82.2M	82.9M
Diluted Shares Outstanding	81.4M	85.3M	83.3M	82.2M	84.1M
Profitability Metrics
EBITDA	267.0M	274.2M	(28.4M)	29.9M	156.7M
D&A	23.1M	21.8M	32.2M	36.2M	35.6M
EBIT	244.0M	252.4M	(60.6M)	(6.3M)	121.1M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026